机器人辅助能否提高全髋关节置换术后达到最小临床重要改善的可能性?基于1,364例手术的倾向评分匹配分析
该回顾性倾向评分匹配分析纳入341例机器人辅助全髋关节置换术(rTHA)与1,023例手动全髋关节置换术(mTHA),比较术后1年最小临床重要改善(MCID-I)与恶化(MCID-W)率、90天并发症率及2年无翻修生存率。结果显示两组各项患者报告结局的MCID-I与MCID-W率均无显著差异,90天再入院率与2年无翻修生存率亦无显著差异。作者结论认为两种术式临床重要改善、并发症及无翻修生存率相似。
要点
- rTHA与mTHA术后1年HOOS-PS的MCID-I率分别为80.3%与85.3%,差异无统计学意义(P=0.063)。
- 两组PROMIS整体生理、整体心理及生理功能简表10a的MCID-I与MCID-W率均无显著差异(均P>0.05)。
- 90天再入院率rTHA 8.5% vs mTHA 8.3%(P=0.67),2年无翻修生存率两组均为98.5%(P=0.99)。
核心结论
- 机器人辅助全髋关节置换术与手动全髋关节置换术在临床重要改善率、并发症率及无翻修生存率方面相似,两种术式术后1年均显示良好结局。
- 作者认为进一步研究应探讨rTHA与mTHA之间的长期差异。
研究设计与样本
- 回顾性分析341例机器人辅助全髋关节置换术(rTHA),按倾向评分1:3匹配1,023例手动全髋关节置换术(mTHA),匹配因素为年龄、性别、体重指数和Charlson合并症指数。
- 所有全髋关节置换术于2016年至2022年间实施。
主要发现
- 髋关节残疾与骨关节炎结局评分-生理功能简表(HOOS-PS)的MCID-I率mTHA 85.3% vs rTHA 80.3%(P=0.063),MCID-W率mTHA 5.2% vs rTHA 7.6%(P=0.16)。
- PROMIS整体生理、PROMIS整体心理及PROMIS生理功能简表10a的MCID-I与MCID-W率在两组间均相当(均P>0.05)。
- 90天再入院率mTHA 8.3% vs rTHA 8.5%(P=0.67),2年无翻修生存率两组均为98.5%(P=0.99),均无显著差异。
关键数值与推荐
- MCID-I与MCID-W基于PROMIS整体生理、PROMIS整体心理、PROMIS生理功能简表10a及HOOS-PS评估,于术后1年比较。
- 并发症评估为90天再入院率,生存评估为2年无翻修生存率。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Robotic-assisted total hip arthroplasty (rTHA) is associated with improved component positioning compared to manual THA (mTHA). However, its impact on achieving the minimal clinically important difference (MCID) in patient-reported outcomes remains unclear. This study compared rates of MCID for improvement (MCID-I), MCID for worsening (MCID-W), and complication rates between rTHA and mTHA. METHODS: We performed a retrospective analysis of 341 rTHAs, matched 1:3 by propensity score to 1,023 mTHAs based on age, sex, body mass index, and Charlson Comorbidity Index. All THAs were performed between 2016 and 2022. Patient-reported outcomes included Patient-Reported Outcomes Measurement Information System (PROMIS) global physical, PROMIS global mental, PROMIS physical function short form 10a, and the Hip Disability and Osteoarthritis Outcome Score-physical function short form. We compared the rates of MCID-I and MCID-W between rTHA and mTHA at one year postoperatively, as well as 90-day complication rates and 2-year revision-free survival. RESULTS: For Hip Disability and Osteoarthritis Outcome Score-physical function short form, MCID-I rates were similar between mTHA and rTHA (85.3 versus 80.3%; P = 0.063), as were MCID-W rates (5.2 versus 7.6%; P = 0.16). Rates of MCID-I and MCID-W for PROMIS global physical, PROMIS global mental, and PROMIS physical function short form 10a were also comparable between the groups (all P > 0.05). Additionally, no significant differences were found in 90-day readmission rates (mTHA: 8.3 versus rTHA: 8.5%; P = 0.67) or 2-year revision-free survival (98.5% for both groups; P = 0.99). CONCLUSIONS: Robotic-assisted THA and mTHA have similar rates of clinically important improvements, complications and revision-free survival. Both approaches demonstrate excellent outcomes at one year. Further research should investigate long-term differences between rTHA and mTHA.
引用
- Lim PL, Gonzalez MR, Wang KY, et al. Does Robotic Assistance Increase the Likelihood of Achieving the Minimal Clinically Important Improvement Following Total Hip Arthroplasty? Findings From a Propensity Score Matched Analysis of 1,364 Procedures. J Arthroplasty. 2025. PMID: 40349870. doi:10.1016/j.arth.2025.05.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。